Due to the current situation, all Lunch Talks are cancelled until further notice. We hope that we can continue with the lecture series soon.

Lunch Talk Series

In the “Lunch Talk Series”, group leaders from BioMed X Innovation Center and the PostDoc Network of the German Cancer Research Center invite renowned life science researchers to join them for a scientific exchange on novel research approaches.

The monthly lunch talks are a great meeting opportunity for researchers and students in the field of life sciences, with focus on cell biology, immunology, bioinformatics, neuroscience and nanomaterials.

The talks begin with one hour of presentation followed by informal discussions and networking during a sponsored lunch.

Topic areas

  • Nanomaterial-Based Biosensors for Near-Patient Testing
  • Epigenetics and Chronic Obstructive Pulmonary Disease (COPD)
  • Tau-Mediated Neurodegeneration in Alzheimer’s Disease
  • Brain Microcircuits in Psychiatric Diseases
  • DNA Damage in Cancer
  • Pathogen-Mediated Modulation of Innate Immunity
  • RNA Splicing in Cancer
  • Rapid Identification of Auto-Antigens in Autoimmune Diseases
  • Intestinal Epithelial Barrier in Autoimmune Diseases
  • Early Intervention in Psychiatric Diseases

Former Speakers

  • Anton Khmelinskii, IMB Mainz, Germany, “Dissecting selective protein degradation in health and disease”,
  • Aleksandra Pekowska, Nencki Institute of Experimental Biology PAS, Poland, “Shaping Chromatin Structure in Development and Transcriptional Regulation”
  • Olatz Pampliega, Achucarro Basque Center for Neuroscience, Spain, “Understanding Cilia-Mediated Autophagy in the Central Nervous System”
  • Michael Stürzl, Medical Immunology Campus Erlangen, Germany, “Pathogenic Impact of the Interplay of Inflammation and Blood Vessels in Colorectal Carcinoma and Inflammatory Bowel Diseases”
  • Gunter Meister, University of Regensburg, Germany, “Gene Regulation Mediated by Non-Coding RNAs, RNA Binding Proteins and RNA Modifications”
  • Jürgen Wienands, Georg August University Göttingen, Germany, “Primary and Secondary B Cell Activation”
  • Tiago C. Luis, Imperial College London, United Kingdom, “A Role for the Bone Marrow Niche in Regulating the Hematopoietic Stem Cell Response to Stress Hematopoiesis”
  • Leopold Parts, Sanger Institute, United Kingdom, “Mapping, Screening, and Modeling Cellular Traits”
  • Albert Jeltsch, University of Stuttgart, Germany, “Novel Insights into the Roles of Epigenetic Enzymes and Readers in Health and Disease”
  • Walter Karlen, ETH Zurich, Switzerland, “Where There is No Doctor – A Mobile Health Approach”
  • Robert Lucas, University of Manchester, United Kingdom, “Photoreception beyond Rods and Cones”
  • Elena Cattaneo, University of Milan, Italy, “Neurons from Stem Cells for Huntington’s Disease Research: Combining Genetics with Cell Biology and Evolution”
  • Christoph Becker, University Hospital Erlangen, Germany, “Epithelial Cell Death Regulation in Intestinal Inflammation and Cancer Development”
  • Irit Sagi, Weizmann Institute of Science Rehovot, Israel, “Harnessing Extracellular Matrix (ECM) Remodeling Mechanisms to Promote Normal Tissue Homeostasis Offers Novel Therapeutic Strategies”
  • Martin Fuhrmann, German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany, “How Memories are Stored and Recalled – Insights from Alzheimer’s Disease Models”
  • Nicola Zamboni, ETH Zurich, Switzerland, “Metabolism by Masses, Metabolomics for the Masses, and Masses of Metabolomes.”
  • John Overington, Medicines Discovery Catapult, United Kingdom, “Knowledge Discovery From Drug Discovery Data”
  • Jacqueline Shields, University of Cambridge, United Kingdom, “Stromal Function in the Evolving Tumour Microenvironment: A Role in Immune Modulation?”
  • Robert Prevedel, EMBL Heidelberg, Germany, “Imaging Brains in Action – Using Advanced Optical Techniques to Visualize Dynamic Events in Living Organisms”
  • Hendrik Dietz, Technical University of Munich, Germany, “Molecular Systems Engineering with DNA”
  • Albert van den Berg, University of Twente, The Netherlands, “Labs, Cells and Organs on a Chip: Technologies and Biomedical Applications”
  • Florian I. Schmidt, Institute of Innate Immunity, University of Bonn, Germany, “Alpaca Nanobodies as Tools to Study the Cell Biology of the Immune System”
  • Matthias Selbach, Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany, “Proteome Dynamics”
  • Simone Picelli, German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany, “Single-cell RNA-sequencing made simple, efficient and inexpensive”
  • Frank Pfrieger, Institute of Cellular and Integrative Neuroscience(INCI) CNRS, University of Strasbourg, France, “Neuron-glia interactions: models matter”
  • Amit Agarwal, Solomon H. Snyder Dept. of Neuroscience, Johns Hopkins University, Baltimore, USA, “Decoding Microdomain Calcium Signals in Astrocytes”
  • Simon Anders, University of Heidelberg, ZMBH, Heidelberg, Germany, “Diving in the Data Deluge: Interactive Tools for Visual Exploration of Big Data”
  • Matthias Leisegang, Goethe University Frankfurt, Germany, “Long Noncoding RNAs In the Control of Endothelial Gene Regulatory Networks”
  • Stefan Diez, B CUBE – Center for Molecular Bioengineering, Technical University Dresden, Germany, “Biomolecular Motors: From Biological Function to Nanotechnological Applications”
  • Mohamed Bentires-Alj, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland, “Cancer targeted therapy and tumor heterogeneity: Act locally think globally”
  • Michael N. Hall, Biozentrum, University of Basel, Switzerland, “mTOR signaling in growth and metabolism”
  • Bassem Hassan, Institut du Cerveau et de la Moëlle épinière – ICM (Brain and Spine Institute), Paris, France, “Transcriptional regulation of neurogenesis”
  • Harald Janovjak, Assistant Professor in Synthetic Physiology, Institute of Science and Technology Austria, “Synthetic physiology – Remote control of cellular signals”
  • Elias Hobeika, Research Group Leader, Institute for Immunology, Ulm University, Germany, “Maintenance of mature B-cells in health and disease”
  • Andreas Offenhäusser, Director at the Peter Grünberg Institute at FZ Jülich, Germany, “Bioelectronics: building connections between bio systems and electronics”
  • Ulrich Stelzl, Professor at the Institute of Pharmaceutical Sciences (IPW), Department of Pharmaceutical Chemistry, University of Graz, Austria, “Studying post-translational protein modification in a human protein interaction network context”
  • Jesus Gil, Cell Proliferation Group, MRC Clinical, Sciences Centre London, United Kingdom, “Linking senescence and inflammation: the senescenceassociated secretory phenotype (SASP)”
  • Dimitrios Tzalis, founder and CEO of Taros, “European Lead Factory: Boosting European Drug Discovery”
  • Janos Vörös, Institute for Biomedical Engineering, ETH Zurich, Switzerland: “Next generation biosensors based on nanotechnology, miniaturized immunofiltration, plasmonic coupled particles and molography.”
  • Oliver Rocks, Group Leader Rho GTPase Signaling, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany, “A systematic analysis of the Rho GEF/GAP regulatory proteins”
  • Markus Zweckstetter, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany, “Molecular mechanisms of Tau function and Alzheimer pathology”
  • Petr Broz, University Basel, Switzerland, “Molecular mechanisms of inflammasome assembly and signalling”
  • Thijn Brummelkamp, Netherlands Cancer Institute, Amsterdam, the Netherlands, “Genetics in haploid human cells to study disease networks”
  • Almut Schulze, Department of Biochemistry and Molecular Biology Theodor-Boveri-Institute, Biocenter, Würzburg, Germany, “Targeting cancer metabolism”
  • Stefan Knapp, Structural Genomics Consortium, University Frankfurt, Germany, “Strategies for the design of selective kinase chemical tools and their role in target validation”

Upcoming Lunch Talks

No upcoming Events